Further, we observed that highly aggressive MYCN-amplified NB tumors have higher expression of RAF1 and MAP2K2, which correlates with disease relapse or reoccurrence conditions in the Versteeg dataset (Figure 1G,H and Figure 2E,F). This evidence concerns the gene MAP2K2 and neuroblastoma.